Magnoflorine inhibits cisplatin-induced protective autophagy by down-regulating HMGB1 and increases drug sensitivity in drug-resistant ovarian cancer cells

Ovarian cancer (OC) is a prevalent type of gynecologic malignancy, and to improve its treatment effectiveness, it is essential to identify new and more potent therapeutic drugs. Magnoflorine is a fundamental chlorine alkaloid with various pharmacological properties, including anti-diabetic and anti-inflammatory effects. However, whether Magnoflorine can inhibit the protective autophagy induced by cisplatin by modulating (high-mobility group B1) HMGB1 requires further investigation. This study aims to assess the impact of Magnoflorine on cisplatin resistance in OC. Our findings demonstrate that Magnoflorine enhances the sensitivity of OC cells to cisplatin. Additionally, it promotes apoptosis in cisplatin-resistant OC cells and simultaneously inhibits cisplatin-induced protective autophagy. Mechanistically, Magnoflorine reduces HMGB1 expression in cisplatin-resistant OC cells. Collectively, these results suggest that Magnoflorine has potential as a therapeutic agent for cisplatin-resistant OC in future clinical applications.

Ovarian cancer; Cisplatin; Apoptosis; Autophagy; HMGB1

[1] Gloss B, Moran-Jones K, Lin V, Gonzalez M, Scurry J, Hacker NF, et al. ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer. Molecular Cancer. 2014; 13: 3.

[2] Pickwell-Smith B, Greenley S, Lind M, Macleod U. Where are the inequalities in ovarian cancer care in a country with universal healthcare? A systematic review and narrative synthesis. Journal of Cancer Policy. 2023; 39: 100458.

[3] Ma Y, Wei Z, Bast RC, Wang Z, Li Y, Gao M, et al. Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo. Laboratory Investigation. 2016; 96: 37–48.

[4] He H, Feng Y, Zang L, Liu W, Ding L, Chen L, et al. Nitric oxide induces apoptosis and autophagy; autophagy down-regulates no synthesis in physalin A-treated a375-S2 human melanoma cells. Food and Chemical Toxicology. 2014; 71: 128–135.

[5] He J, Zhang G, Pang Q, Yu C, Xiong J, Zhu J, et al. SIRT6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox-LDL condition. The FEBS Journal. 2017; 284: 1324–1337.

[6] Tan J, Jiang X, Yin G, He L, Liu J, Long Z, et al. Anacardic acid induces cell apoptosis of prostatic cancer through autophagy by ER stress/DAPK3/Akt signaling pathway. Oncology Reports. 2017; 38: 1373–1382.

[7] Ghezelayagh TS, Wu ES, Barber EL, Dao MD, Zsiros E, Urban RR, et al. Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study. European Journal of Gynaecological Oncology. 2023; 44: 17–25.

[8] Chen CD, Dai LN, Wang M, Lai XH, Wang J. Hypoxia induces autophagy in PA-l ovarian teratoma cells and resistance to growth inhibition and apoptosis by chemotherapeutic agent cis-diamminedichloroplatinum. European Journal of Gynaecological Oncology. 2017; 38: 277–281.

[9] Zhu J, Lin S, Zou X, Chen X, Liu Y, Yang X, et al. Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin. Molecular Biology Reports. 2023; 50: 6457–6468.

[10] Okon E, Kukula-Koch W, Halasa M, Jarzab A, Baran M, Dmoszynska-Graniczka M, et al. Magnoflorine-isolation and the anticancer potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 rhabdomyosarcoma cancer cells. Biomolecules. 2020; 10: 1532.

[11] Yadav A, Singh A, Phogat J, Dahuja A, Dabur R. Magnoflorine prevent the skeletal muscle atrophy via Akt/mTOR/FoxO signal pathway and increase slow-MyHC production in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology. 2021; 267: 113510.

[12] Sun X, Zhang X, Zhai H, Zhang D, Ma S. Magnoflorine inhibits human gastric cancer progression by inducing autophagy, apoptosis and cell cycle arrest by JNK activation regulated by ROS. Biomedicine & Pharmacotherapy. 2020; 125: 109118.

[13] Wei T, Xiaojun X, Peilong C. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways. Biomedicine & Pharmacotherapy. 2020; 121: 109139.

[14] Xu T, Jiang L, Wang Z. The progression of HMGB1-induced autophagy in cancer biology. OncoTargets and Therapy. 2018; 12: 365–377.

[15] Burges A, Schmalfeldt B. Ovarian cancer: diagnosis and treatment. Deutsches Ärzteblatt International. 2011; 108: 635–641.

[16] Zhong L, Qin Y, Liu M, Sun J, Tang H, Zeng Y, et al. Magnoflorine improves cognitive deficits and pathology of Alzheimer’s disease via inhibiting of JNK signaling pathway. Phytomedicine. 2023; 112: 154714.

[17] Wang L, Li P, Zhou Y, Gu R, Lu G, Zhang C. Magnoflorine ameliorates collagen-induced arthritis by suppressing the inflammation response via the NF-kB/MAPK signaling pathways. Journal of Inflammation Research. 2023; 16: 2271–2296.

[18] Liang H, Chang X, Xia R, Wu W, Guo H, Yang M. Magnoflorine attenuates cerebral ischemia-induced neuronal injury via autophagy/sirt1/AMPK signaling pathway. Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 1–11.

[19] Zhang L, Liu Y, Lei X, Liu X, Sun H, Liu S. Astragaloside II enhanced sensitivity of ovarian cancer cells to cisplatin via triggering apoptosis and autophagy. Cell Biology International. 2023; 47: 1600–1613.

[20] Zhou Y, Liu T, Wu Q, Wang H, Sun Y. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1a/ATG5 axis. Molecular Carcinogenesis. 2023; 62: 1474–1486.

[21] Baran M, Miziak P, Bonio K. Magnoflorsine—a compound with anti-tumour activity. Journal of Pre-Clinical and Clinical Research. 2020; 14: 98–101.